Antibodies, repertoires and microdevices in antibody discovery and characterization
Open access
Date
2024-03-07Type
- Review Article
Abstract
Therapeutic antibodies are paramount in treating a wide range of diseases, particularly in auto-immunity, inflammation and cancer, and novel antibody candidates recognizing a vast array of novel antigens are needed to expand the usefulness and applications of these powerful molecules. Microdevices play an essential role in this challenging endeavor at various stages since many general requirements of the overall process overlap nicely with the general advantages of microfluidics. Therefore, microfluidic devices are rapidly taking over various steps in the process of new candidate isolation, such as antibody characterization and discovery workflows. Such technologies can allow for vast improvements in timelines and incorporate conservative antibody stability and characterization assays, but most prominently screenings and functional characterization within integrated workflows due to high throughput and standardized workflows. First, we aim to provide an overview of the challenges of developing new therapeutic candidates, their repertoires and requirements. Afterward, this review focuses on the discovery of antibodies using microfluidic systems, technological aspects of micro devices and small-scale antibody protein characterization and selection, as well as their integration and implementation into antibody discovery workflows. We close with future developments in microfluidic detection and antibody isolation principles and the field in general. Show more
Permanent link
https://doi.org/10.3929/ethz-b-000651577Publication status
publishedExternal links
Journal / series
Lab on a ChipVolume
Pages / Article No.
Publisher
Royal Society of ChemistryOrganisational unit
09676 - Eyer, Klaus (ehemalig) / Eyer, Klaus (former)
Funding
197619 - Functionally targeted single-cell sequencing - Applications for antibody discovery (SNF)
More
Show all metadata